V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210003803 | 210013775 | null | 83.6 | Palliative (P) | 2021-12-31 | 2022-01-01 | Trastuzumab Subcutaneous | null | N | TRASTUZUMAB | 100784792 |
| 210003805 | 210013776 | 1.61 | 83 | null | null | 2020-06-29 | Docetaxel | null | null | DOCETAXEL | 100072693 |
| 210003809 | 210013778 | 1.66 | 67.7 | Adjuvant (A) | null | 2021-03-01 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101688181 |
| 210003813 | 210013779 | 1.57 | 60 | Palliative (P) | null | 2021-12-09 | Trastuzumab | 02 | N | TRASTUZUMAB | 101270324 |
| 210003821 | 210013781 | 1.66 | 48 | Palliative (P) | 2021-04-22 | 2021-09-07 | Paclitaxel 7 day | 02 | N | PACLITAXEL | 101309940 |
| 210003824 | 210013782 | null | 79.4 | Neo-adjuvant (N) | 2019-03-09 | 2019-03-29 | EC | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100036411 |
| 210003830 | 210013784 | 1.61 | 72.9 | Adjuvant (A) | null | 2022-02-03 | Paclitaxel 7 day | 02 | N | PACLITAXEL | 101383942 |
| 210003832 | 210013785 | 1.52 | 61.7 | Adjuvant (A) | 2019-12-15 | 2020-01-01 | Docetaxel | null | N | DOCETAXEL | 100586130 |
| 210003834 | 210013786 | 1.64 | 60.4 | Palliative (P) | 2019-03-16 | 2019-09-15 | Trastuzumab | 02 | N | TRASTUZUMAB | 100149178 |
| 210003844 | 210013787 | 1.51 | 69.1 | null | null | 2021-11-25 | Docetaxel 100mg/m2 (21 day) | null | null | DOCETAXEL | 100348651 |
| 210003845 | 210013788 | 1.65 | 72.7 | Palliative (P) | 2022-01-22 | 2022-03-21 | null | 02 | N | ROSCO TRIAL | 100474186 |
| 210003850 | 210013789 | 1.47 | 52.2 | Palliative (P) | null | 2020-02-04 | TCH (21 day Trastuzumab) Maint | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100865385 |
| 210003852 | 210013790 | 1.49 | 92.2 | null | 2020-05-12 | 2020-06-01 | Eribulin | 02 | null | ERIBULIN | 100647356 |
| 210003858 | 210013791 | 1.6 | 73 | Neo-adjuvant (N) | null | 2017-07-25 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | null | N | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 101594501 |
| 210003862 | 210013793 | 1.58 | 62.1 | Palliative (P) | null | 2020-11-11 | GemCarbo Days 1+8 | 02 | N | CARBOPLATIN + GEMCITABINE | 100376955 |
| 210003864 | 210013794 | 1.58 | 63.9 | null | 2019-11-03 | 2020-01-27 | Capecitabine + Cisplatin | null | null | ROSCO TRIAL | 100309071 |
| 210003872 | 210013797 | 0 | 90 | Palliative (P) | 2022-02-22 | 2022-05-27 | Carboplatin + Docetaxel | 02 | N | CARBOPLATIN + DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100048535 |
| 210003874 | 210013798 | null | null | null | null | 2019-10-03 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | null | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 101181685 |
| 210000062 | 210013800 | 1.64 | 77.8 | Palliative (P) | 2020-05-17 | 2020-05-18 | FEC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100225173 |
| 210000730 | 210013803 | 1.58 | 95.8 | Palliative (P) | 2020-01-16 | 2020-01-25 | Letrozole + Palbociclib | null | N | PACLITAXEL + TRASTUZUMAB | 100737972 |
| 210001086 | 210013805 | 1.59 | 64.2 | Neo-adjuvant (N) | 2021-11-22 | 2022-02-02 | FEC 100 + DOCETAXEL | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 101663547 |
| 210001120 | 210013807 | 1.66 | 66 | Neo-adjuvant (N) | 2021-02-28 | 2021-05-18 | null | N | N | LETROZOLE + PALBOCICLIB | 100823922 |
| 210001126 | 210013808 | 1.59 | 0 | Adjuvant (A) | 2020-02-20 | 2020-03-18 | null | null | N | CARBOPLATIN + PACLITAXEL | 101674658 |
| 210001616 | 210013810 | 1.6 | 91.6 | Palliative (P) | 2019-02-27 | 2019-03-05 | null | 02 | N | EC | 101284861 |
| 210001833 | 210013811 | 1.63 | 70 | Palliative (P) | null | 2018-08-20 | Capecitabine | null | N | CAPECITABINE | 101799390 |
| 210001876 | 210013812 | 1.61 | 80 | Palliative (P) | 2020-10-10 | 2020-11-14 | FEC | 02 | N | CARBOPLATIN + DOCETAXEL | 100936518 |
| 210002107 | 210013815 | 1.62 | 61.9 | Adjuvant (A) | 2019-12-08 | 2019-12-23 | FEC 100 | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 101536240 |
| 210002127 | 210013816 | 1.67 | 88.6 | null | 2021-06-25 | 2021-07-09 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | null | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100657281 |
| 210002144 | 210013817 | 1.63 | 90.5 | Palliative (P) | 2021-09-02 | 2021-11-05 | Pertuzumab (Loading) | null | N | PERTUZUMAB | 100163344 |
| 210002229 | 210013818 | 1.52 | 56.25 | Neo-adjuvant (N) | 2020-05-13 | 2020-05-27 | null | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 101584469 |
| 210003476 | 210013827 | 1.58 | 61.4 | null | 2019-10-25 | 2020-03-23 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | null | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100010778 |
| 210003548 | 210013828 | 1.7 | 54.3 | Palliative (P) | 2019-08-03 | 2019-10-27 | Capecitabine | 02 | N | CAPECITABINE | 100525179 |
| 210003725 | 210013829 | 1.5 | 64.4 | Palliative (P) | 2021-10-31 | 2021-11-05 | Capecitabine | null | N | CAPECITABINE | 100388097 |
| 210003879 | 210013830 | 1.68 | 70.6 | Palliative (P) | 2021-12-09 | 2021-12-16 | Capecitabine | 02 | null | CAPECITABINE | 100017528 |
| 210003751 | 210013874 | 1.61 | 52 | Adjuvant (A) | null | 2021-07-01 | Docetaxel | 02 | null | DOCETAXEL | 101566613 |
| 210003792 | 210013877 | null | null | Adjuvant (A) | 2020-09-18 | 2022-01-24 | Docetaxel 100mg/m2 (21 day) | null | N | DOCETAXEL | 100133076 |
| 210003797 | 210013878 | 1.45 | 81 | null | 2022-04-29 | 2022-05-12 | EC | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100216251 |
| 210003803 | 210013879 | 1.61 | 57.9 | Adjuvant (A) | 2022-01-23 | 2022-02-02 | Docetaxel | 02 | N | DOCETAXEL | 100784792 |
| 210003805 | 210013880 | null | null | null | null | 2020-07-13 | EC | 01 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100072693 |
| 210003809 | 210013882 | 1.67 | 0 | Adjuvant (A) | null | 2021-05-14 | Paclitaxel 7 day | 02 | N | PACLITAXEL | 101688181 |
| 210003821 | 210013884 | null | 84.9 | Adjuvant (A) | null | 2021-10-20 | Docetaxel | 02 | N | DOCETAXEL | 101309940 |
| 210003824 | 210013885 | 1.58 | 90.4 | Palliative (P) | 2019-03-22 | 2019-06-08 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 100036411 |
| 210003845 | 210013889 | null | 58 | Neo-adjuvant (N) | null | 2022-04-11 | Docetaxel | null | N | DOCETAXEL | 100474186 |
| 210003852 | 210013890 | 1.71 | 78.7 | null | 2020-07-11 | 2020-07-24 | Trastuzumab Subcutaneous | 02 | null | TRASTUZUMAB | 100647356 |
| 210003858 | 210013891 | 1.58 | 125 | Adjuvant (A) | 2017-09-06 | 2017-09-13 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | PACLITAXEL | 101594501 |
| 210003862 | 210013893 | 1.52 | 62 | null | null | 2021-01-25 | Trastuzumab Subcutaneous | N | null | TRASTUZUMAB | 100376955 |
| 210003864 | 210013894 | 1.61 | 87.6 | Adjuvant (A) | 2019-11-16 | 2020-02-17 | Vinorelbine IV | 02 | N | VINORELBINE | 100309071 |
| 210003870 | 210013895 | null | null | null | 2021-03-17 | 2021-09-03 | Carboplatin + Docetaxel | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 101050368 |
| 210003874 | 210013898 | 1.63 | 66 | null | 2019-08-05 | 2019-11-08 | Capecitabine | null | null | CAPECITABINE | 101181685 |
| 210000062 | 210013899 | 1.64 | 77.2 | null | null | 2020-05-18 | FEC 100 | null | null | FULVESTRANT + PALBOCICLIB | 100225173 |